Pre-treatment with AMD in a METH-exposed environment maintained downstream PI3K signaling pathways, including Akt (df = 11, p < 0.05) and mTOR (df = 11, p < 0.05 compared to METH-treated). This evidence concerns the gene AKT1 and age-related macular degeneration.